AI Against Parkinson's
Built for people navigating a Parkinson's diagnosis and the caregivers who love them.
Every morning, AI agents search clinical trials, medical journals, and research databases to bring you the latest breakthroughs, trials, and evidence-based tips.
Get daily reports by email
Free. No spam. Unsubscribe anytime. Powered by AI research agents.
No account required. Free forever.
Why Subscribe?
Every new treatment, clinical trial, and scientific discovery could change someone's life. This report brings those findings straight to your inbox — no jargon, no confusion, just what you need to know.
Parkinson's Research
2026-04-09
Clinical Trials
A Phase 2a multicenter study is evaluating TB006, an investigational antibody therapy, in participants with Parkinson's disease. The trial is currentl...
Breakthrough Treatments
Japan approved AMCHEPRY on March 6, 2026 — the world's first iPS stem cell therapy for Parkinson's disease. Unlike drugs that only manage symptoms, th...
Lifestyle Interventions
The Parkinson's Foundation and the American College of Sports Medicine issued updated exercise recommendations in February 2026, building on their 202...
Quick Actions
Clinical Trials
Active recruiting trials, Phase 2/3 results, eligibility criteria
Breakthroughs
FDA approvals, drug mechanisms, clinical evidence
Lifestyle
Exercise protocols, diet plans, sleep optimization
Emerging Research
Preprints, novel targets, biomarkers, diagnostics
What's Tracked
"When my dad was diagnosed with Parkinson's, I wanted a way to keep up with all the latest breakthroughs and research without having to search through dozens of medical websites. So I built this — so families like ours can quickly understand what works, which trials are recruiting, and what promising treatments are on the horizon."
Tyler Delano
From the Founder